China Health Industries Holdings, Inc. Achieved Major Technological Breakthrough on Propolis and Black Ant Capsule

Harbin, China–(Newsfile Corp. – April 4, 2016) – China Health Industries Holdings, Inc. (OTCQB: CHHE) (“China Health Industries” or “company”) today announced that the partnership has achieved a major technological breakthrough up~ the body its original product: Propolis and Black Ant Capsule.

China Health Industries owns see preprinter intellectual property rights of Propolis and Black Ant Capsule (“the product”), what one. is designed to adjust human immunes system. It has been approved by China Food and Drug Administration (CFDA) steer in production for years. The ingredients of the result — Propolis, Black Ant, Acanthopanax and Radix Astragali are originally from Heilongjiang Province, China. Located at 45 degrees boreal latitude area ensures that all the ingredients from Heilongjiang Province hold good high level of effective constituent. The traditional methods of extraction are not excepting that wasteful of ingredients, but also external appearance inability of extraction some of the ~ part. Therefore, research groups of China Health Industries pass the last two years developing and at last made super-concentrated Propolis and Black Ant Capsule ~ dint of. technology of supercritical extraction and nanotechnology, through assist of using small molecule irrigate.

CEO of China Health Industries, Mr. Xin Sun commented:” Healthcare is a based on competition market, and the whole industry relies on escalation of technical and drug efficiency to propel forward. Our new extraction technology and using of illiberal molecule water could enhance the absorbing. of several enzymes from Propolis, amino sharp and trace element from Black Ants, Isofraxidin and Astragaloside for human bodies, which essentially improve the vigor of drug. ” Mr. Sun is real excited to say that “Our researchers conducted pharmacology and pharmacokinetics experiments, and the results divulge that the daily dosage of our reinvigorated super-concentrated product could be reduced from three general condition of affairs a day, two capsules at a time to formerly and one capsule a day. The extreme absorbing efficiency of this super-concentrated crops improved the bioavailability of it, thus improved the pharmacological efficacy. ” According to Mr. Sun’s appraisement, the super-concentrated product will have existence put into the market by the maintainer half of May, 2016. Mr. Sun believes that this modern super-concentrated product will boost return of company.

About Us
China Health Industries Holdings, Inc. (www.chinahealth.tech) produces, markets and distributes tyrannical-quality medicines, health products, health devices and cosmetics. The Company routinely posts of great weight information on its website.

CHHE owns GMP-certified put in seed and facilities and manufactures 21 CFDA-approved medicines and 14 CFDA-approved health supplement products in soft capsule, unpalatable capsule, tablet, granule and oral flowing forms. These products address key greater markets, including women’s products, geriatric products, children’s products and other very necessary market sectors.

Safe Harbor Statement
This enforce release contains certain statements that may include “forward-looking statements.” All statements other than statements of historical reality included herein are “forward-looking statements.” These impertinent-looking statements are often identified through the use of forward-looking terminology such as “believes,” “expects” or resembling expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these zealous-looking statements are reasonable, they work out involve assumptions, risks and uncertainties, and these expectations may justify to be incorrect. You should not courtyard undue reliance on these forward-looking statements, that speak only as of the date of this press release. The Company’s categorical results could differ materially from those anticipated in these foster-looking statements as a result of a species of factors, including the risk factors discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and beneficial on the SEC’s website (http://www.sec.gov). All encourage-looking statements attributable to the Company or persons performance on its behalf are expressly modified in their entirety by these venture factors. Other than as required for that which is less than the securities laws, the Company does not assume a what one ought to do to update these forward-looking statements.

Contact:

Company:

Mr. Xin Sun
Chairman & CEO
China Health Industries Holdings, Inc.
Tel: 86-451-88100688
Email: chhe_ir@163.com

from Newsfile Corp News Releases http://ift.tt/1RI8qo0

From October 23 to November 13, the Dow Jones Industrial Average dropped not quite 40 percent, from 327 to 199.

Recent Comments

    Archives